Bristol-Myers Squibb Company <BMY.N>: Wells Fargo Raises Target Price to $65 From $60
BMY•Related News
Builders FirstSource <BLDR.N>: Oppenheimer cuts target price to $90 from $110
BLDR•
Oxford Square Capital Q2 net investment income rises to $5.1 million; NAV per share falls to $1.29
OXSQ•
Moog Q3 sales beat on growth across segments, lifts FY outlook
MOG.A•
Cannae Holdings, Inc. Sells Its Ownership Interest In The Watkins Company To Kdsa Investment Partners
CNNE•
US Q2 employment costs data
SPY•